Isofol announces start of study data analysis of phase III AGENT study in advanced metastatic colorectal cancer ...Middle East

PR Newswire - News
Isofol announces start of study data analysis of phase III AGENT study in advanced metastatic colorectal cancer
GOTHENBURG, Sweden, April 22, 2022 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced the start of data analysis of the multi-center, global Phase III AGENT Study investigating arfolitixorin in combination with 5-FU, oxaliplatin and bevacizumab in...

Hence then, the article about isofol announces start of study data analysis of phase iii agent study in advanced metastatic colorectal cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Isofol announces start of study data analysis of phase III AGENT study in advanced metastatic colorectal cancer )

Apple Storegoogle play

Last updated :

Also on site :



Latest News